REMUS

Remus Pharma Ltd, incorporated in 2015, operates within the pharmaceutical industry primarily focusing on the trading and export of active pharmaceutical ingredients (API) and finished formulations. The company also provides technical consultancy services and engages in the marketing and distribution of finished dosage formulations. Serving various therapeutic segments, Remus Pharma concentrates on export markets. It employs a decentralized manufacturing approach by collaborating with third-party manufacturers. The company does not have publicly listed shares or reported subsidiaries and its key management and founding personnel are not specified.